evidence: This COVID-19 pandemic has unknotted many of the gains that India made with vaccination campaigns for polio, cholera, measles, diphtheria, and meningitis. In 1997, with the support of IVI, India revealed its potential for manufacturing vaccines. Serum Institute of India (SII) developed the first meningitis vaccine which was pre-qualified by WHO in 2010 [7]. The world’s first typhoid conjugate vaccine (TCV) by Bharat Biotech International was launched in 2013 [8]. The multi-dose inactivated polio vaccine (IPV) from Bilthoven Biological was released in 2017. The first fully liquid hexavalent vaccine based on whole-cell pertussis was developed by Panacea Biotech of India, in the same year in 2017. The Serum Institute of India developed the first thermostable rotavirus vaccine [9]. All vaccines are pre-qualified by WHO. India is the only country in the DCVMN network that has as many as 23 pre-qualified vaccines. [...] Free distribution to immediate neighbors such as Bangladesh, Afghanistan, and other South Asian Association of Regional Cooperation (SAARC) countries. [...] Drishya Pathak & A. Philo Magdalene